RANIBIZUMAB

CHEBI:CHEBI_751466

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

active_ingredient_strength
100 mg/mL
nui
N0000193542
pharm_class_epc
Vascular Endothelial Growth Factor Inhibitor [EPC]
pharm_class
Vascular Endothelial Growth Factor Inhibitors [MoA]
pharm_class_moa
Vascular Endothelial Growth Factor Inhibitors [MoA]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
generic_name
RANIBIZUMAB
rxcui
2045502
product_type
BULK INGREDIENT
listing_expiration_date
20241231
dosage_form
SOLUTION, CONCENTRATE
package_marketing_start_date
09-JUN-22
marketing_start_date
20161013
marketing_category
BULK INGREDIENT
route
INTRAVITREAL
labeler_name
Labor Zollinger AG
manufacturer_name
Genentech, Inc.
active_ingredient_name
RANIBIZUMAB
product_ndc
83832-111
spl_id
4605e9dd-a350-4d8c-adb9-c14403ad05b6
package_ndc
83832-111-11
package_description
1 SYRINGE, GLASS in 1 BLISTER PACK (83832-111-11) / .05 mL in 1 SYRINGE, GLASS
brand_name
LUCENTIS
brand_name_base
LUCENTIS
application_number
BLA125156
unii
ZL1R02VT79
spl_set_id
de4e66cc-ca05-4dc9-8262-e00e9b41c36d